Tharimmune, Inc. (THAR)
2.53
-0.16
(-5.95%)
USD |
NASDAQ |
Dec 11, 16:00
2.54
+0.01
(+0.40%)
After-Hours: 20:00
Tharimmune Cash from Investing (Quarterly): 0.00 for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp. | -0.007M |
| ETHZilla Corp. | -252.37M |
| Flora Growth Corp. | -0.0092M |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
| Palatin Technologies, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.855M |
| Cash from Financing (Quarterly) | 7.224M |
| Free Cash Flow | -8.720M |
| Free Cash Flow Per Share (Quarterly) | -0.2972 |
| Free Cash Flow to Equity (Quarterly) | -1.716M |
| Free Cash Flow to Firm (Quarterly) | -1.846M |
| Free Cash Flow Yield | -100.9% |